EUVIMEDEUVIMED entdecken
Scoping Review

Asymptomatic Carotid Stenosis: Scoping Review with ☸️SAIMSARA

SAIMSARA Journal · 22.04.2026 · 1 (1)

DOI: 10.62487/saimsara427b99fa ↗

Kurz gefasst

Scoping Review in der Zeitschrift SAIMSARA Journal, online erschienen am 22.04.2026. Die Arbeit nennt 298 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this paper is to synthesize contemporary evidence regarding the natural history, diagnostic innovations, cognitive impacts, and comparative effectiveness of medical and procedural interventions for patients with asymptomatic carotid stenosis. The review utilises 298 references. The mapped evidence suggests that asymptomatic carotid stenosis now carries a lower ipsilateral stroke risk under contemporary medical management than in the historical trial era, with one large modern cohort reporting an annual risk of about 0.9% and a 5-year risk of 4.7% for severe disease managed without surgery. At the same time, risk is not uniform: progression of stenosis, microembolic signals, impaired cerebrovascular reserve, and vulnerable plaque features such as intraplaque hemorrhage, echolucency, ulceration, and neovascularization were repeatedly associated with higher event rates, while moderate stenosis showed very low cumulative ipsilateral stroke risk of 1.2% at 5 years and 2.0% at 10 years in one community cohort. Across treatment topics, carotid endarterectomy and carotid artery stenting appeared to offer broadly similar longer-term protection in selected patients, but perioperative safety often favored endarterectomy, and transcarotid artery revascularization emerged as a promising alternative to transfemoral stenting in contemporary practice. The broader evidence map also indicates that so-called asymptomatic disease is frequently accompanied by covert brain injury, cognitive dysfunction, and systemic vascular risk, supporting a practical shift away from decisions based on stenosis severity alone toward individualized assessment of plaque biology, hemodynamic compromise, life expectancy, frailty, and procedural risk. Future research should prioritize contemporary randomized and prospective studies that integrate standardized imaging, hemodynamic, and cognitive markers to identify the subgroup most likely to benefit from revascularization beyond intensive medical therapy.

Zitieren

APA

(2026). Asymptomatic Carotid Stenosis: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal, 1(1). https://doi.org/10.62487/saimsara427b99fa

Vancouver

Asymptomatic Carotid Stenosis: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal. 2026;1(1). doi:10.62487/saimsara427b99fa

BibTeX
@article{euvimed2026,
  title = {Asymptomatic Carotid Stenosis: Scoping Review with ☸️SAIMSARA},
  journal = {SAIMSARA Journal},
  year = {2026},
  volume = {1},
  number = {1},
  doi = {10.62487/saimsara427b99fa}
}
Kostenlos starten →